The Implementation of Pharmacogenomics Into Primary Care in British Columbia

NACompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
Pharmacogenetics
Interventions
OTHER

Decision support

Saliva samples will be collected from each participant for genetic testing. A genetic report will be fed back to the research server, and into the Family Physicians/pharmacist's electronic record. The electronic record is linked to the UBC TreatGx computer; the next time the participant is seen by the Family Physician / Pharmacist personalized prescribing recommendations will be available for use.

All Listed Sponsors
collaborator

Genome British Columbia

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Roche Pharma AG

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

collaborator

Health Research Foundation

OTHER

collaborator

Janssen, LP

INDUSTRY

lead

University of British Columbia

OTHER